HemaSphere
(Jun 2022)
P912: COVID19 SEVERITY AND THERAPEUTIC OPTIONS IN PATIENTS WITH MULTIPLE MYELOMA
- E. Karimova,
- E. Zhelnova,
- E. Baryakh,
- K. Yatskov,
- E. Zotina,
- E. Grishina,
- E. Paramonova,
- D. Gagloeva,
- E. Misyurina
Affiliations
- E. Karimova
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- E. Zhelnova
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- E. Baryakh
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- K. Yatskov
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- E. Zotina
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- E. Grishina
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- E. Paramonova
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- D. Gagloeva
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- E. Misyurina
- 1 hematology, Moscow city hospital №52, Moscow, Russia
- DOI
-
https://doi.org/10.1097/01.HS9.0000846520.79961.15
- Journal volume & issue
-
Vol. 6
pp.
803
– 804
WeChat QR code